Biosion, Inc.
PrivateLast Round
Series B
Dec 1, 2022
Total Funding Raised
$45.7M
Company Overview
Biosion, Inc. is a clinical-stage biotechnology company that develops antibody-based therapies for immune and oncologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosion, Inc. Comparables
Compare Biosion, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 82% | |
| Belenos Biosciences Inc. | 78% | |
| Adimab | 78% | |
Biosion, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2022 | ||||
| Series B Extension | Dec 9, 2021 | ||||
| VC Round | Dec 10, 2020 |
Biosion, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | Series B Extension |
| GF Xinde Investment Management | Series B |
| Lapam Capital | VC Round |
| Chase Capital | Series B Extension |
| Oceanpine Healthcare Fund | VC Round |
| 建发新兴投资 | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2025
Grew 16% QoQ, from 19 to 22 employees.
Biosion, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biosion, Inc.'s valuation, stock price, and market status.